Breaking News

Novasep Invests €6M to Expand API Capacity at Chasse-sur-Rhône

Includes the addition of a cGMP flow chemistry capability, debottlenecking of drying and purification capacities, and a clean room.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Novasep, a supplier of services and technologies for the life sciences industry, is investing €6 million in its Chasse-sur-Rhône site in France. This investment will increase and modernize manufacturing capabilities to support new generation Active Pharmaceutical Ingredients (APIs), in areas such as oncology, central nervous system (CNS) and infectious diseases.   Continuous, or flow chemistry, is becoming increasingly important in API manufacturing, offering a number of advantages over tradit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters